FindTrial
Sign In

An observational study of management and outcomes of goitre patients with intermediate microscopic category swellings.

Evaluation and Outcomes of TBSRTC 3 Thyroid Nodules- An Observational Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/091093
Enrollment
40
Registered
2025-07-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C73- Malignant neoplasm of thyroid gland

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil Intervention5: Nil: Nil

Sponsors

Punati Vishnu Nandan Naidu
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with Bethesda III (AUS/FLUS) thyroid nodules on fine-needle aspiration (FNA) cytology. 2.Patient undergoing surgical intervention for Bethesda 3(AUS/FLUS)Thyroid nodule

Exclusion criteria

Exclusion criteria: 1.Patients operated previously for a thyroid malignancy. 2.Patients with FNAC report other than BETHESDA 3 thyroid nodule.

Design outcomes

Primary

MeasureTime frame
-To determine the final histopathological findings in Bethesda 3 thyroid nodule for patients who are undergoing surgical intervention. Timepoint: 1year 7months—

Secondary

MeasureTime frame
-To correlate FNAC reporting- Bethesda 3 (AUS/FLUS) thyroid nodule with ultrasound characteristics (e.g. hypoechogenicity, irregular margins, microcalcification etc) TI-RADS classification.Timepoint: 1year 7months—

Countries

India

Contacts

Public ContactDr Pavan M Bhat

Kasturba Medical College

Prasad.ss@manipal.edu8073680789

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026